NO plays a role in LPS-induced decreases in circulating IGF-I and IGFBP-3 and their gene expression in the liver

American Journal of Physiology - Endocrinology and Metabolism

Volumn 286, Issue 1 49-1, 2004, Pages

  Priego, Teresa ^a   Ibanez De Caceres, Inmaculada ^b   Martín, Ana Isabel ^b   Villanúa, M Angeles ^a   López Calderón, Asunción ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD EUROPEA DE MADRID   (Spain)

Author keywords

Aminoguanidine; Growth hormone; Inducible nitric oxide synthase; Insulin like growth factor I; Insulin like growth factor binding protein 3; Lipopolysaccharide; Nitric oxide; Proteolysis

Indexed keywords

AMINOGUANIDINE; ENDOTOXIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SODIUM CHLORIDE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; GENE EXPRESSION; HORMONE BLOOD LEVEL; INJECTION; LIVER; MALE; NITROGEN BALANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; RAT;

EID: 0346157024     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00149.2003     Document Type: Article

References (50)

1. Albiston AL and Herington AC. Cloning and characterisation of the growth hormone-dependent insulin-like growth factor binding protein (IGFBP-3) in the rat. Biochem Biophys Res Commun 166: 892-897, 1990.
2. Bach LA, Dean R, Youssef S, and Cooper ME. Aminoguanidine ameliorates changes in the IGF-I system in experimental diabetic nephropathy. Nephrol Diol Transplant 15: 347-354, 2000.
3. Baratta M, Saleri R, Mainardi GL, Valle D, Giustina A, and Tamanini C. Leptin regulates GH gene expression and secretion and nitric oxide production in pig pituitary cells. Endocrinology 143: 551-557, 2002.
4. Baumbach WR, Horner DL, and Logan JS. The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor. Genes Dev 3: 1199-1205, 1989.
5. Bhat G, Mahesh VB, Aguan K, and Brann DW. Evidence that brain nitric oxide synthase is the major nitric oxide synthase isoform in the hypothalamus of the adult female rat and that nitric oxide potently regulates hypothalamic cGMP levels. Neuroendocrinology 64: 93-102, 1996.
6. Billiar TR, Curran RD, West MA, Hofmann K, and Simmons RL. Kupffer cell cytotoxicity to hepatocytes in coculture requires L-arginine. Arch Surg 124: 1416-1420, 1989.
7. Bocca L, Valenti S, Cuttica CM, Spaziante R, Giordano G, and Giusti M. Nitric oxide biphasically modulates GH secretion in cultured cells of GH-secreting human pituitary adenomas. Minerva Endocrinol 25: 55-59, 2000.
8. Clare BW, Scozzafava A, Briganti F, Lorga B, and Supuran CT. Protease inhibitors. Part 2. Weakly basic thrombin inhibitors incorporating sulfonyl-aminoguanidine moieties as S1 anchoring groups: synthesis and structure-activity correlation. J Enzym Inhib 15: 235-264, 2000.
9. Ceccatelli S, Hulting AL, Zhang X, Gustafsson I, Villar M, and Hokfelt T. Nitric oxide synthase in the rat anterior pituitary gland and the role of nitric oxide in regulation of luteinizing hormone secretion. Proc Natl Acad Sci USA 90: 11292-11296, 1993.
10. Cobb JP, Natanson C, Quezado ZMN, Hoffman WD, Koev CA, Correa R, Levi R, Elin RJ, Hosseini JM, and Danner RL. Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs. Am J Physiol Heart Circ Physiol 268: H1634-H1642, 1995,
11. Colson A, Willens B, and Thissen J-P. Inhibition of TNF-α production by pentoxifylline does not prevent endotoxin-induced decrease in serum IGF-I, J Endocrinol 278: 101-109, 2003.
12. Dahn MS, Lange MP, and Jacobs LA. Insulin-like growth factor-I production is inhibited in human sepsis. Arch Surg 123: 1409-1414, 1988.
13. Defalque D, Brandt N, Ketelslegers JM, and Thissen J-P. GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors. Am J Physiol Endocrinol Metab 276: E565-E572, 1999.
14. Denson LA, Held MA, Menon RK, Frank SJ, Parlow AF, and Arnold DL. Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3. Am J Physiol Gastrointest Liver Physiol 284: G646-G654, 2003.
15. Dogru-Abbasoglu S, Balkan J, Kanbagli O, Cevikbas U, Aykac-Toker G, and Uysal M. Aminoguanidine, an inducible nitric oxide synthase inhibitor, plus N-acetylcysteine treatment reduce the lipopolysaccharide-augmented hepatotoxicity in rats with cirrhosis. Hum Exp Toxicol 21: 359-364, 2002.
16. Donaghy AJ, Delhanty PJD, Ho KK, Willians R, and Baxter RC. Regulation of the growth hormone receptor/binding protein, insulin-like growth factor ternary complex system in human cirrhosis. J Hepatol 36: 751-758, 2002.
17. 3 insulin-like growth factor (IGF)-I decreases hepatic IGF-I mRNA but not IGF binding protein-3 mRNA expression in pigs. Gen Comp Endocrinol 126: 221-228, 2002.
18. Elsasser TH, Khal S, Rumsey TS, and Blum JW. Modulation of growth performance in disease: reactive nitrogen compounds and their impact on cell proteins. Domest Anim Endocrinol 19: 75-84, 2000.
19. Fan J, Char D, Bagby GJ, Gelato MC, and Lang CH. Regulation of insulin-like growth factor-I (IGF-I) and IGF binding proteins by tumor necrosis factor. Am J Physiol Regul Integr Comp Physiol 269: R1204-R1212, 1995.
20. Fan J, Molina PE, Gelato MC, and Lang CH. Differential tissue regulation of insulin-like growth factor-I content and binding proteins after endotoxin. Endocrinology 134: 1685-1692, 1994.
21. Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di Silvio M, Wang SC, Nakayama DK, Simmons RL, Snyder SH, and Billiar TR. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 90: 3491-3495, 1993.
22. Hamada E, Nishida T, Uchiyama Y, Nakamura JI, Isahara K, Kazuo H, Huang TP, Momoi T, Ito T, and Matsuda H. Activation of Kupffer cells and caspase-3 involved in rat hepatocyte apoptosis induced by endotoxin. J Hepatol 30: 807-818, 1999.
23. Harada S, Imaki T, Chikada N, Naruse M, and Demura H. Distinct distribution and time-course changes in neuronal nitric oxide synthase and inducible NOS in the paraventricular nucleus following lipopolysaccharide injection. Brain Res 821: 322-332, 1999.
24. Hsu CM, Wang JS, Liu CH, and Chen LW. Kupffer cells protects liver from ischemia-reperfusion injury by an inducible nitric oxide synthase-dependent mechanism. Shock 17: 280-285, 2002.
25. Hwang TL and Yeh CC. Hemodynamic and hepatic microcirculational changes in endotoxemic rats treated with different NOS inhibitors. Hepatogastroenterology 50: 188-191, 2003.
26. Inomata M, Hayashi M, Shumiya S, Kawashima S, and Ito Y. Aminoguanidine-treatment results in the inhibition of lens opacification and calpain-mediated proteolysis in shumiya cataract rats. J Biochem (Tokyo) 128: 771-776, 2000.
27. Kasting NW and Martin JB. Altered release of growth hormone and thyrotropin induced by endotoxin in the rat. Am J Physiol Endocrinol Metab 243: E332-E333, 1982.
28. Katsanos K, Tsatsoulis A, Christodoulou D, Challa A, Katsaraki A, and Tsianos EV. Reduced serum insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 levels in adults with inflammatory bowel disease. Growth Horm IGF Res 11: 364-367, 2001.
29. Lamson G, Giudice LC, and Rosenfeld RG. A simple assay for the proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3). J Clin Endocrinol Metab 72: 1391-1393, 1991.
30. Lang CH, Frost RA, Jefferson LS, Kimball SR, and Vary TC. Endotoxin-induced decrease in muscle protein synthesis is associated with changes in elF2B, elF4E, and IGF-I. Am J Physiol Endocrinol Metab 278: E1133-E1143, 2000.
31. López-Calderón A, Ibáñez de Cáceres I, Soto L, Priego T, Martin AI, and Villanúa MA. The decrease in hepatic IGF-I gene expression in arthritic rats is not associated with modifications in hepatic GH receptor mRNA. Eur J Endocrinol 144: 529-534, 2001.
32. MacMicking JD, Natham C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, and Hutchinson N. Altered response to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81: 641-650, 1995.
33. Miranda KM, Espey MG, and Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 1: 62-71, 2001.
34. Pinilla L, Tena-Sampere M, and Aguilar E. Nitric oxide stimulates growth hormone secretion in vitro through a calcium- and cyclic guanosine monophosphate-independent mechanism. Horm Res 51: 242-247, 1999.
35. Priego T, Ibáñez de Cáceres I, Martín AI, Villanúa MA, and López-Calderón A. Glucocorticoids are not necessary for the inhibitory effect of endotoxic shock on serum insulin-like growth factor (IGF)-I and hepatic IGF-I messenger RNA. J Endocrinol 172: 449-456, 2002.
36. Priego T, Ibáñez de Cáceres I, Martin Al, Villanúa MA, and López-Calderón A. Hepatic IGFBP-3 gene expression in rats with endotoxic shock: role of glucocorticoids. Ann NY Acad Sci 973: 88-90, 2002.
37. Priego T, Ibáñez de Cáceres I, Martin AI, Villanúa MA, and López-Caldérón A. Endotoxin decreases serum IGFBP-3 and liver IGFBP-3 mRNA: comparison between Lewis and Wistar rats. Mol Cell Endocrinol 199: 23-28, 2003.
38. Roberts CT, Lasky SR, Lowe WL, Seaman WT, and LeRoith D. Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extra hepatic tissues. Mol Endocrinol 1: 243-248, 1987.
39. Soto L, Martín AI, Millán S, Vara E, and López-Calderón A. Effects of endotoxin lipopolysaccharide administration on the somatotropic axis. J Endocrinol 159: 239-246, 1998.
40. Trachtman H, Futterweit S, Garg P, Reddy K, and Singhal PC. Nitric oxide stimulates the activity of a 72-kDa neutral matrix metalloproteinase in cultured rat mesangial cells. Biochem Biophys Res Commun 218: 704-708, 1996.
41. Tunctan B, Uludag O, Altug S, and Abacioglu N. Effects of nitric oxide synthase inhibition in lipopolysaccharide-induced sepsis in mice. Pharmacol Res 38: 405-411, 1998.
42. Turner CH, Owan L, Jacob DS, McClintock R, and Peacock M. Effects of nitric oxide synthase inhibitors on bone formation in rats. Bone 21: 487490, 1997.
43. Valverde I, Peñalva A, Ghigo E, Casanueva FF, and Dieguez C. Involvement of nitric oxide in the regulation of growth hormone secretion in dogs. Neuroendocrinology 74: 213-219, 2001.
44. Vankelecom H, Matthys P, and Denef C. Inducible nitric oxide synthase in the anterior pituitary gland: induction by interferon in a subpopulation of folliculostellae cells and in a unidentified population of non-hormone-secreting cells. J Histochem Cytochem 45: 847-857, 1997.
45. Vankelecom H, Matthys P, and Denef C. Involvement of nitric oxide in the interferon-γ-induced inhibition of growth hormone and prolactin secretion in anterior pituitary cell cultures. Mol Cell Endocrinol 129: 157-167, 1997.
46. Vodovotz Y, McCloskey C, Shapiro R, Green A, and Billiar TR. The hepatocyte as a microbial product-responsive cell. J Endotoxin Res 7: 365-367, 2001.
47. Voerman HJ, Strack RJM, Groeneveld ABJ, de Boer H, and Nauta JP. Effects of recombinant human growth hormone in patients with severe sepsis. Ann Surg 216: 648-655, 1992.
48. Watanabe N, Miura S, Zeki S, and Ishii H. Hepatocellular oxidative DNA injury induced by macrophage-derived nitric oxide. Free Radic Biol Med 30: 1019-1028, 2001.
49. Zamora R, Vodovotz Y, Aulak KS, Kim PKM, Kane IIIJM, Alarcon L, Stuehr DJ, and Billiar TR. A DNA microarray study of nitric oxide-induced genes in mouse hepatocytes: implications for hepatic heme oxygenase-I expression in ischemia/reperfusion. Nitric Oxide 7: 165-186, 2002.
50. Zhang GL, Wang YH, Teng HL, and Lin ZB. Effects of aminoguanidine on nitric oxide production induced by inflammatory cytokines and endotoxin in cultured rat hepatocytes. World J Gastroenterol 7: 331-334, 2001.